Skip to content

Mobilaser Study to Help With People Who Are Having Problems With Their Gait

Increasing Mobility in Parkinsonian Patients With Freezing of Gait and Gait Hypokinesia With an Adjustable, Attachable Laser (Mobilaser)

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01581645
Enrollment
11
Registered
2012-04-20
Start date
2012-05-31
Completion date
2013-12-31
Last updated
2015-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinsonism, Parkinson's Disease

Keywords

Parkinson's disease, Parkinsonism, Gait problems, Freezing gait

Brief summary

Does use of the Mobilaser reduce freezing of gait (FOG) and stride reduction in patients with Parkinson's disease and Parkinsonism.

Detailed description

Can patients walk faster and have less freezing when using the mobilaser then when not using it

Interventions

DEVICEMobilaser

Patients will begin by collecting data at home without using the mobilaser. They will then be given the mobilaser to use at home for 6 weeks while they collect data on whether their gait has improved. They will then have to return the Mobilaser to the clinic and collect data at home for 3 days to see if there is a difference.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Parkinsonian patients with Freezing of Gait or Gait hesitation. * Must have evidence of bradykinesia ambulating (stride reduction or reduced arm swing) * Must have a constant caregiver

Exclusion criteria

* No cardiopulmonary contraindications to ambulation, e.g., unstable angina pectoris; * Severe arthritis; * Cerebellar or sensory ataxia; * Recent knee or hip surgery

Design outcomes

Primary

MeasureTime frame
Improvement in Gait6 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026